Guntupalli L et al
The STEP 1 trial (N=1,961) published in the New England Journal of Medicine in 2021 (DOI: 10.1056/NEJMoa2032183) demonstrated 14.9% mean body weight reduction with semaglutide 2.4mg weekly versus 2.4% with placebo over 68 weeks
Reduces appetite for sugar-rich foods
Among patients with type 2 diabetes, diarrhea occurs in about 10.62% of cases, while constipation affects 7.92%
Contact a healthcare professional if symptoms become severe, persistent, or start affecting your daily activities
In an in vitro study on microglial cells, PYC dose-dependently decreased the release of nitric oxide, tumor necrosis factor- (TNF-), interleukin (IL)-6, IL-1, ICAM-1, and perilipin 2, thereby exhibiting anti-inflammatory activity (Fan et al., 2015)